Oval Medical maintains momentum at Cambridge Research Park
Cambridge Pharma Ltd has joined sister business Oval Medical Technologies Ltd – both part of the SMC Ltd group of companies – on the fast growing Enterprise Zone of Cambridge Research Park.
Cambridge Pharma Ltd will provide pharmaceutical services to both Oval and to third parties. Oval designs, develops and industrialises patient-centric autoinjectors .
This latest deal follows lettings to Oval Medical Technologies, Applied Medical Technologies and TeraView who occupy a total of 41,445 sq ft, meaning 55 per cent of the scheme is now let.
Rupert Dando, surveyor in the business space team at Savills Cambridge, told Business Weekly: “Royal London’s Enterprise scheme, which was developed in partnership with XLB, provides premium and flexible mid-tech accommodation ideal for the thriving Cambridge R & D sector.
“Consequently, Enterprise has attracted a range of occupiers drawn away from the traditional northern cluster due to its competitive rents, R & D capabilities and Enterprise Zone benefits.
“What’s more, the potential to incorporate bespoke innovative fit-outs has seen businesses who would usually occupy office space, consider these multi-functional buildings. There are now only five units remaining ranging in size from 6,000 sq ft to 14,000 sq ft.”
Cambridge Pharma Ltd was advised by Carter Jonas.